1. Home
  2. TUYA vs EYPT Comparison

TUYA vs EYPT Comparison

Compare TUYA & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tuya Inc. each representing one

TUYA

Tuya Inc. each representing one

HOLD

Current Price

$2.42

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

EYPT

EyePoint Pharmaceuticals Inc.

HOLD

Current Price

$13.49

Market Cap

1.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
TUYA
EYPT
Founded
2014
1987
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
2021
2005

Fundamental Metrics

Financial Performance
Metric
TUYA
EYPT
Price
$2.42
$13.49
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$3.49
$31.80
AVG Volume (30 Days)
1.8M
1.8M
Earning Date
01-01-0001
05-18-2026
Dividend Yield
4.98%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$7,539,000.00
Revenue This Year
$13.29
N/A
Revenue Next Year
$14.65
$965.51
P/E Ratio
$27.45
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.87
$3.91
52 Week High
$3.95
$19.11

Technical Indicators

Market Signals
Indicator
TUYA
EYPT
Relative Strength Index (RSI) 54.31 38.49
Support Level $2.29 $11.88
Resistance Level $2.44 $14.24
Average True Range (ATR) 0.11 1.13
MACD -0.01 -0.44
Stochastic Oscillator 32.73 9.80

Price Performance

Historical Comparison
TUYA
EYPT

About TUYA Tuya Inc. each representing one

Tuya Inc is an AI cloud platform service provider dedicated to bringing AI into everyday life. The group leverages its TuyaOpen open-source framework and universal AI Agent engines, including the AI Agent development platform, to integrate multimodal AI capabilities and reduce barriers to AI development. It drives the adoption of AI-powered lifestyles and speeds up the integration of AI with the physical world. It offers innovative physical AI solutions for smart devices, commercial use, and industry developers using cloud computing and spatial intelligence. It also provides a complete, open, and neutral global AIoT ecosystem. It builds a developer community that collaborates to create smart solutions grounded in sustainability, security, efficiency, agility, and openness.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Inc focuses on developing and commercializing innovative therapeutics for serious retinal diseases. It develops therapies for serious retinal diseases to provide durable treatments that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained release product candidate for retinal diseases with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.

Share on Social Networks: